4 Drug Stocks Facing FDA Approval Decisions in July

Description:

According to Adam Feuerstein, " Four FDA drug approval decisions in July -- headlined by another weight-loss drug and a prescription fish oil pill with blockbuster potential -- will keep biotech investors busy in what is normally one of the sector's slower months." Read more here.

>>Also: Hot Biotech Stocks Traded by Hedge Funds

>>Also: 22 Biopharma Stocks With Breakout Potential in 2012

Most Viewed Portfolios

View All

Articles

4 Big Stocks on Traders' Radars

08.27.14 | 02:52 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

4 Stocks Spiking on Big Volume

08.28.14 | 09:01 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter